AUTL

Autolus Therapeutics plc

Investor Moves

NameValueActionChangePriceCurrent Price
Jim SimonsRenaissance Technologies
$3.2M2.3M shares
TrimQ1 2026
$3.0M
$1.38
$1.68
Ken GriffinCitadel Advisors
$808k585.8k shares
TrimQ1 2026
$1.6M
$1.38
$1.68
Paul Tudor Jones IITudor Investment
$64k46.2k shares
TrimQ1 2026
$498k
$1.38
$1.68
Steven CohenPoint72
$589k427k shares
TrimQ1 2026
$18k
$1.38
$1.68
Ken GriffinCitadel Advisors
$2.4M1.2M shares
TrimQ4 2025
$7.5M
$1.99
$1.68
Jim SimonsRenaissance Technologies
$6.2M3.1M shares
TrimQ4 2025
$1.8M
$1.99
$1.68

News

globenewswire.comAutolus Therapeutics Receives Prix Galien UK Awardglobenewswire.comJun 12zacks.comAutolus Therapeutics (AUTL) Could Find a Support Soon, Here's Why You Should Buy the Stock Nowzacks.comJun 10zacks.comAutolus Therapeutics PLC Sponsored ADR (AUTL) Just Flashed Golden Cross Signal: Do You Buy?zacks.comJun 1globenewswire.comAutolus Therapeutics to Participate in Upcoming Investor Conferencesglobenewswire.comMay 27globenewswire.comAutolus Therapeutics to Present Clinical Data Update at the American Society of Clinical Oncology Annual Meeting 2026globenewswire.comMay 21